# CRIO

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/crio

- Industry: Software
- Headquarters: Boston, US
- Website: www.clinicalresearch.io
- Total disclosed funding: $15M
- Latest round: Series B (Jan 11, 2022)
- Investors on record: 5

## About

Founded in 2015 and based in Massachusetts, US, Crio Inc., is a firm passionate about transforming clinical research through innovation. They are creating a holistic paperless platform for conducting clinical trials that will reduce data errors, streamline regulatory workflows, and accelerate timelines. In May 2024, CRIO, Inc. raised an undisclosed amount of venture funding from new investor The Riverside Company.

Crio Inc. offers powerfully integrated eSource, eRegulatory, CTMS, and stipend solutions built for sites. Clinical Research IO's software frees a person from inefficient, error-prone binders because investigators can choose between tablets and desktop computers to capture source data. Its autofill and data validation tools reduce protocol deviations and save time. With patient scheduling, recruiting, and financial management, the company provides an all-in-one enterprise solution. Crio Inc. has partnered with over 600 sites globally and is growing, all aligned with the vision of moving research forward. Clinical Research IO keeps the source data secure, so that anyone can access it anytime, anywhere.

The company will use the May 2024 funding to expand its product offerings and strengthen its value to clinical research and biopharmaceutical companies..

## Funding rounds

- Series B, Jan 11, 2022, $9M — Rally Ventures, Abbhi Capital, NXT Ventures
- Series A, Jan 25, 2021, $2M — Boston Millennia Partners, Rally Ventures
- Seed, Dec 1, 2017, $1.7M — Rally Ventures, Bantam Group, NXT Ventures
- Angel, Dec 28, 2016, $1.6M — Rally Ventures, NXT Ventures
- Seed, Jan 16, 2016, $0.4M — Rally Ventures, NXT Ventures

## Investors

- Rally Ventures (https://capitalatlas.ai/funds/rally-ventures) — Seed, Angel, Series A, Series B
- NXT Ventures (https://capitalatlas.ai/funds/nxt-ventures) — Seed, Angel, Series B
- Bantam Group — Seed
- Boston Millennia Partners (https://capitalatlas.ai/funds/boston-millennia-partners) — Series A
- Abbhi Capital (https://capitalatlas.ai/funds/abbhi-capital) — Series B